Department of Health and Social Care (DHSC) has issued a medicine supply notification for Methylprednisolone (Medrone®) 4mg tablets.


Tier 2 – medium impact

Date of issue 25th August 2022

Methylprednisolone (Medrone®) 4mg tablets will be out of stock from 15th September 2022 until mid-January 2023.
Methylprednisolone (Medrone®) 2mg tablets remain available but cannot support an increase in demand.
Prednisolone tablets remain available and can support an uplift in demand.

A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.

DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.

The Tool also details any changes to resupply dates and updates to the entries.

To access the Tool you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

The post Medicine Supply Notification: Methylprednisolone (Medrone®) 4mg tablets appeared first on PSNC Website.